CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands |
6 Months Ended |
Jun. 27, 2020 |
Jun. 29, 2019 |
| Operating activities: |
|
|
| Net loss |
$ (11,156)
|
$ (14,812)
|
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
| Stock-based compensation |
6,225
|
5,714
|
| Depreciation and amortization |
7,006
|
4,644
|
| Asset retirements and write-downs |
3,749
|
138
|
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable, net |
(12,082)
|
6,840
|
| Inventory |
3,494
|
4,791
|
| Prepaid expenses and other assets |
1,175
|
1,697
|
| Accounts payable |
(671)
|
(2,676)
|
| Accrued liabilities |
7,868
|
(10,314)
|
| Deferred revenue |
(947)
|
3,223
|
| Other long-term liabilities |
(726)
|
(2,496)
|
| Net cash provided by (used in) operating activities |
3,935
|
(3,251)
|
| Investing activity – |
|
|
| Purchases of property and equipment |
(4,480)
|
(9,538)
|
| Financing activities: |
|
|
| Proceeds from exercise of stock options |
5,608
|
326
|
| Proceeds from employee stock purchase plans |
4,712
|
4,157
|
| Taxes paid for awards vested under equity incentive plan |
0
|
(156)
|
| Payments related to financing arrangements |
(1,529)
|
(1,267)
|
| Proceeds from line of credit |
30,000
|
89,000
|
| Repayment of line of credit |
(34,000)
|
(94,000)
|
| Payments to originate the line of credit |
(285)
|
0
|
| Net cash provided by (used in) financing activities |
4,506
|
(1,940)
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(238)
|
25
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
3,723
|
(14,704)
|
| Cash, cash equivalents and restricted cash at beginning of period |
47,457
|
50,274
|
| Cash, cash equivalents and restricted cash at end of period |
$ 51,180
|
$ 35,570
|